| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a693232b92910547c898db10feb83fef |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 |
| filingDate |
2013-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4300155dddef3fe196613ce38ca16766
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf874230780a0cfe3acee9fcda6faca8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee7bcecac75c80d0852fa8892b16097a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fbc44074c753a30be1b06a502c0ab2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99e410050242f9587649bbc09d3f6c7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2499413ada3be7809f8a3a07a4b232b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6aaf7dc0eaa59d32a9d390269a02a77f |
| publicationDate |
2017-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-107082783-A |
| titleOfInvention |
PDE9 inhibitors with imidazotriazinone skeleton |
| abstract |
The present invention is directed to compounds that are inhibitors of the PDE9 enzyme. The present invention provides a pharmaceutical composition, which comprises a therapeutically effective amount of the compound of the present invention and a pharmaceutically acceptable carrier. The present invention also provides processes for the preparation of compounds of formula (I). The present invention further provides a method of treating a subject suffering from a neurodegenerative disorder, the method comprising administering to the subject a therapeutically effective amount of a compound of formula (I). The invention further provides a compound of formula (I) for use in a method of treating a subject suffering from a mental disorder, the method comprising administering to the subject a therapeutically effective amount of a compound of formula (I). |
| priorityDate |
2012-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |